Amylyx Pharmaceuticals Inc. monthly returns
Amylyx Pharmaceuticals Inc. has averaged 3.87% per month, positive in 57% of months. Month-by-month returns for Amylyx Pharmaceuticals Inc. (AMLX) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Amylyx Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -1.1% | |
| Sep 2026 | -13.8% | |
| Aug 2026 | +66.2% | |
| Jul 2026 | +13.1% | |
| Jun 2026 | +25.2% | |
| May 2026 | -10.3% | |
| Apr 2026 | +15.1% | |
| Mar 2026 | -8.4% | |
| Feb 2026 | +6.2% | |
| Jan 2026 | +18.3% | |
| Dec 2025 | -19.4% | |
| Nov 2025 | +7.5% | |
| Oct 2025 | +2.5% | |
| Sep 2025 | +44.9% | |
| Aug 2025 | +16.8% | |
| Jul 2025 | +25.3% | |
| Jun 2025 | +24.5% | |
| May 2025 | +0.8% | |
| Apr 2025 | +44.4% | |
| Mar 2025 | +7.9% | |
| Feb 2025 | -10.1% | |
| Jan 2025 | -3.4% | |
| Dec 2024 | -31.8% | |
| Nov 2024 | +2.6% | |
| Oct 2024 | +66.7% | |
| Sep 2024 | +45.9% | |
| Aug 2024 | +7.8% | |
| Jul 2024 | +8.4% | |
| Jun 2024 | +10.5% | |
| May 2024 | -5.0% | |
| Apr 2024 | -36.3% | |
| Mar 2024 | -84.9% | |
| Feb 2024 | +17.8% | |
| Jan 2024 | +8.7% | |
| Dec 2023 | +4.0% | |
| Nov 2023 | -13.2% | |
| Oct 2023 | -10.9% | |
| Sep 2023 | -15.1% | |
| Aug 2023 | -8.1% | |
| Jul 2023 | +8.7% | |
| Jun 2023 | -12.6% | |
| May 2023 | -13.1% | |
| Apr 2023 | -3.2% | |
| Mar 2023 | -15.7% | |
| Feb 2023 | -11.2% | |
| Jan 2023 | +6.1% | |
| Dec 2022 | -3.7% | |
| Nov 2022 | +7.6% | |
| Oct 2022 | +26.7% | |
| Sep 2022 | +11.5% | |
| Aug 2022 | -6.5% | |
| Jul 2022 | +40.1% | |
| Jun 2022 | +116.6% | |
| May 2022 | -1.2% | |
| Apr 2022 | -30.0% | |
| Mar 2022 | -60.9% | |
| Feb 2022 | +41.9% |
Monthly total return (since Jan 2023)#
Amylyx Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2023, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -1.13% — 3rd of 4 Octobers since 2023 at the last close; the average October returned +19.4%.
| Month | −85%0+85% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +7.4% | +7.4% | 75% | +18.3% 2026 | -3.4% 2025 | |
| Feb | +0.7% | -2.0% | 50% | +17.8% 2024 | -11.2% 2023 | |
| Mar | -25.3% | -12.1% | 25% | +7.9% 2025 | -84.9% 2024 | |
| Apr | +5.0% | +6.0% | 50% | +44.4% 2025 | -36.3% 2024 | |
| May | -6.9% | -7.6% | 25% | +0.8% 2025 | -13.1% 2023 | |
| Jun | +11.9% | +17.5% | 75% | +25.2% 2026 | -12.6% 2023 | |
| Jul | +13.9% | +10.9% | 100% | +25.3% 2025 | +8.4% 2024 | |
| Aug | +20.7% | +12.3% | 75% | +66.2% 2026 | -8.1% 2023 | |
| Sep | +15.5% | +15.6% | 50% | +45.9% 2024 | -15.1% 2023 | |
| Oct | +19.4% | +2.5% | 67% | +66.7% 2024 | -10.9% 2023 | |
| Nov | -1.0% | +2.6% | 67% | +7.5% 2025 | -13.2% 2023 | |
| Dec | -15.7% | -19.4% | 33% | +4.0% 2023 | -31.8% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from AMLX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Amylyx Pharmaceuticals Inc.'s average monthly return?
- Amylyx Pharmaceuticals Inc. (AMLX) has averaged about 3.87% per month, positive in roughly 57% of months. The best month was Oct 2024 (+66.7%) and the worst was Mar 2024 (-84.9%).